Pre- and/or post-operative immunochemotherapy for advanced digestive cancer.
Saji
S
S
Second Department of Surgery, Gifu University School of Medicine, Japan.
Sugiyama
Y
Y
Kunieda
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D015179:Colorectal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D007912:Lentinan / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy*; D011182:Postoperative Care; D011509:Proteoglycans / Q000008:administration & dosage*; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate
D011509:Proteoglycans; D007912:Lentinan; C010770:polysaccharide-K; D002945:Cisplatin; D005472:Fluorouracil